CPT® Code 90649

The Human Papillomavirus (HPV) vaccine is designed to provide protection against specific types of HPV that are known to cause various health issues, including cervical cancer. This vaccine is administered through intramuscular injection and follows a multi-dose schedule, specifically a three-dose regimen. Unlike immune globulins, which offer temporary, passive immunity, vaccines like the HPV vaccine work by stimulating the recipient's immune system to develop its own long-lasting immunity. This is achieved by introducing an altered version of the virus, prompting the immune system to produce antibodies that can recognize and combat the actual virus if encountered in the future. The HPV virus comprises over 100 different types, some of which can lead to benign warts, while others, particularly high-risk strains, are associated with the development of cervical cancer. The effectiveness of the vaccine is maximized when administered before the individual has been exposed to the virus, thereby preventing infection and its potential long-term consequences. The CPT® Code 90649 specifically refers to the quadrivalent (4vHPV) vaccine, which targets types 6, 11, 16, and 18, and is part of a three-dose schedule. This code is used solely to report the supply of this particular vaccine product, distinguishing it from other HPV vaccines that target different strains, such as the bivalent (2vHPV) and nonavalent (9vHPV) vaccines, which are reported under different CPT® codes.